Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 09:30 am Purchase | 2024-12-31 | 13G | Vera Therapeutics, Inc. VERA | venBio Select Advisor LLC | 5,610,000 8.900% | 1,300,410 (+30.17%) | Filing History |
| 2024-11-14 4:10 pm Sale | 2024-09-30 | 13G | Vera Therapeutics, Inc. VERA | COMMODORE CAPITAL LP | 2,475,000 4.500% | -1,425,000 (-36.54%) | Filing History |
| 2024-11-14 4:05 pm Sale | 2024-02-29 | 13G | Vera Therapeutics, Inc. VERA | COMMODORE CAPITAL LP | 3,900,000 7.300% | -1,550,000 (-28.44%) | Filing History |
| 2024-11-14 1:22 pm Purchase | 2024-09-30 | 13G | Vera Therapeutics, Inc. VERA | PRICE T ROWE ASSOCIATES INC | 3,939,109 7.200% | 3,939,109 (New Position) | Filing History |
| 2024-11-14 12:15 pm Sale | 2024-09-30 | 13G | Vera Therapeutics, Inc. VERA | Kynam Capital Management LP | 1,576,549 2.490% | -2,073,790 (-56.81%) | Filing History |
| 2024-11-14 09:35 am Purchase | 2024-09-30 | 13G | Vera Therapeutics, Inc. VERA | venBio Select Advisor LLC | 4,309,590 7.900% | 4,309,590 (New Position) | Filing History |
| 2024-11-12 10:34 am Purchase | 2024-11-08 | 13G | Vera Therapeutics, Inc. VERA | FMR LLC | 2,785,284 5.080% | 10,912 (+0.39%) | Filing History |
| 2024-11-04 7:49 pm Purchase | 2024-10-31 | 13D | Vera Therapeutics, Inc. VERA | Longitude Capital Partners IV LLC | 5,184,062 8.400% | 20,000 (+0.39%) | Filing History |
| 2024-03-26 7:57 pm Sale | 2024-03-22 | 13D | Vera Therapeutics, Inc. VERA | Sofinnova Venture Partners X L.P. | 2,813,837 5.400% | -834,459 (-22.87%) | Filing History |
| 2024-02-20 7:11 pm Purchase | 2024-01-30 | 13D | Vera Therapeutics, Inc. VERA | Sofinnova Venture Partners X L.P. | 3,648,296 6.900% | 171,215 (+4.92%) | Filing History |
| 2024-02-14 4:57 pm Sale | 2023-12-31 | 13G | Vera Therapeutics, Inc. VERA | CITADEL ADVISORS LLC | 43,447 0.100% | -1,948,106 (-97.82%) | Filing History |
| 2024-02-14 4:10 pm Purchase | 2023-12-31 | 13G | Vera Therapeutics, Inc. VERA | COMMODORE CAPITAL LP | 5,450,000 12.300% | 448,217 (+8.96%) | Filing History |
| 2024-02-14 4:05 pm Purchase | 2023-06-14 | 13G | Vera Therapeutics, Inc. VERA | COMMODORE CAPITAL LP | 5,001,783 11.300% | 2,658,926 (+113.49%) | Filing History |
| 2024-02-14 3:21 pm Unchanged | 2023-12-31 | 13G | Vera Therapeutics, Inc. VERA | Ares Trading S.A. | 1,913,501 3.600% | 0 (Unchanged) | Filing History |
| 2024-02-14 12:49 pm Purchase | 2023-12-31 | 13G | Vera Therapeutics, Inc. VERA | Kynam Capital Management LP | 3,650,339 8.220% | 2,241,241 (+159.06%) | Filing History |
| 2024-02-12 4:38 pm Purchase | 2023-12-31 | 13G | Vera Therapeutics, Inc. VERA | Woodline Partners LP | 1,140,632 2.200% | 1,140,632 (New Position) | Filing History |
| 2024-02-09 10:05 am Sale | 2024-02-08 | 13G | Vera Therapeutics, Inc. VERA | FMR LLC | 2,774,372 6.243% | -533,238 (-16.12%) | Filing History |
| 2024-02-05 4:45 pm Purchase | 2024-02-01 | 13D | Vera Therapeutics, Inc. VERA | Longitude Capital Partners IV LLC | 5,164,062 9.800% | 9,925 (+0.19%) | Filing History |
| 2024-01-29 5:25 pm Purchase | 2023-12-31 | 13G | Vera Therapeutics, Inc. VERA | BlackRock Inc. BLK | 2,754,894 6.200% | 2,754,894 (New Position) | Filing History |
| 2023-11-13 09:02 am Sale | 2023-11-10 | 13G | Vera Therapeutics, Inc. VERA | FMR LLC | 3,307,610 7.463% | -841,036 (-20.27%) | Filing History |